BioNexus Gene Lab Corp
BGLC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.22M
Close$
$-0.79
185.8% downside
Current Fair Value
185.8% downsideOvervalued by 185.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.22 Million |
|---|---|
| Enterprise Value | $1.19 Million |
| Earnings per Share | $-1.61 |
| Beta | 2.2 |
| Outstanding Shares | 2,417,314 |
Return
| Return on Equity | -33.11% |
|---|---|
| Return on Assets | -29.51% |
| Return on Invested Capital | -32.41% |
Valuation & Multiples
| P/E Ratio | -0.73 |
|---|---|
| PEG | 1.36 |
| Price to Sales | 0.92 |
| Price to Book Ratio | 0.31 |
| Enterprise Value to Revenue | 0.38 |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.60%▲ 0.59% |
|---|---|
| Total Invested | $27,199▲ 5372.64% |
| Investors Holding | 3▲ 1.00% |